3M Co (MMM) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Sep 24, 2026
3M Co (MMM)
A forensic read on 3M Co built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
8.1
Distress distance
Clean
Earnings quality
4
Forensic signals
28.6
P / E (ttm)
69.1%
ROE
$87.8B
Market cap
6.25%
Dividend yield
1.5%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
3M Co earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 8.1, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by shareholder returns.
What the filings flag
345% of FCF
FY2025
Shareholder returns.Returned $4.8B to shareholders (buybacks + dividends) in FY2025 — 345% of free cash flow. That is $3.4B (245%) more than free cash flow covered, and more than operating cash flow as well. Over FY2025 total debt fell $442M, so that line did not fund the gap; it was met from balance-sheet lines this read does not cover. A payout past free cash flow draws the balance sheet down in every year it continues, which isn't sustainable indefinitely. Counting the $225M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 361%.
52d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 47 to 52 days FY2024→FY2025 (receivables +11% vs revenue +2%). Receivables are creeping up relative to sales. Across FY2023–FY2025 the day count ran 53 → 47 → 52 days, so the latest reading sits on top of a record that was flat or falling before it — one year's move, not a direction the business has been travelling in. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2024's opening balance is on file, but across the 3 fiscal years read here (FY2023–FY2025) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.
11.8%
FY2025
Return on invested capital.Return on invested capital is 11.8% in the latest fiscal year and rising across FY2023–FY2025 from -23%. The capital base behind it came down -18% across FY2023–FY2025, from $36.4B to $29.8B, so this is a return struck on a smaller base rather than a record of money put to work.
-40%
FY2023→FY2024
Dividend — cut.
Key fundamentals
Latest Revenue$24.95B
Revenue Growth YoY+1.5%
Revenue CAGR (2yr)+0.7%
Net Margin13.0%
Free Cash Flow$1.40B
Return on Equity69.1%
Debt / Equity2.68x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from 3M Co's actual 10-K/10-Q/8-K filings?